Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Global Manufacturing of CAR T Cell Therapy.
Levine BL, Miskin J, Wonnacott K, Keir C. Levine BL, et al. Among authors: keir c. Mol Ther Methods Clin Dev. 2016 Dec 31;4:92-101. doi: 10.1016/j.omtm.2016.12.006. eCollection 2017 Mar 17. Mol Ther Methods Clin Dev. 2016. PMID: 28344995 Free PMC article. Review.
Impact of low-grade adverse events on health-related quality of life in adult patients receiving imatinib or nilotinib for newly diagnosed Philadelphia chromosome positive chronic myelogenous leukemia in chronic phase.
Guérin A, Chen L, Ionescu-Ittu R, Marynchenko M, Nitulescu R, Hiscock R, Keir C, Wu EQ. Guérin A, et al. Among authors: keir c. Curr Med Res Opin. 2014 Nov;30(11):2317-28. doi: 10.1185/03007995.2014.944973. Epub 2014 Aug 5. Curr Med Res Opin. 2014. PMID: 25025755 Clinical Trial.
Building blocks for institutional preparation of CTL019 delivery.
McGuirk J, Waller EK, Qayed M, Abhyankar S, Ericson S, Holman P, Keir C, Myers GD. McGuirk J, et al. Among authors: keir c. Cytotherapy. 2017 Sep;19(9):1015-1024. doi: 10.1016/j.jcyt.2017.06.001. Epub 2017 Jul 25. Cytotherapy. 2017. PMID: 28754600 Free article. Review.
Evaluating the Impact of a Switch to Nilotinib on Imatinib-Related Chronic Low-Grade Adverse Events in Patients With CML-CP: The ENRICH Study.
Cortes JE, Lipton JH, Miller CB, Busque L, Akard LP, Pinilla-Ibarz J, Keir C, Warsi G, Lin FP, Mauro MJ. Cortes JE, et al. Among authors: keir c. Clin Lymphoma Myeloma Leuk. 2016 May;16(5):286-96. doi: 10.1016/j.clml.2016.02.002. Epub 2016 Feb 16. Clin Lymphoma Myeloma Leuk. 2016. PMID: 26993758 Free PMC article. Clinical Trial.
19 results